Prevalence of Chronic Kidney Disease in Patients with Cardiovascular Disease
Abstract
The chronic kidney disease, often known as CKD, is an urgent illness that affects people all over the globe. There is a tight physiological interaction between the heart and the kidneys, despite the fact that they are physically separated from one another by a significant distance inside the body and perform quite different roles. It is possible for disorders affecting the kidneys to cause problems affecting the heart, and vice versa. The most important component in the onset and progression of chronic kidney disease is hypertension, which refers to both high blood pressure and high blood pressure levels (CKD). The objective of preventing the progression of CKD is to lower blood pressure. Chronic abnormalities in cardiac function (such as chronic congestive heart failure), chronic kidney disease, and anemia appear to act together in a vicious circle in which each condition causes or exacerbates the other progressive chronic kidney disease. This may be due to the fact that chronic kidney disease appears to be caused by chronic abnormalities in cardiac function. The purpose of this research was to determine the prevalence of chronic renal disease in patients with cardiovascular disease who was receiving treatment at the JLNMC, Bhagalpur, Bihar. Methods: This is a cross-sectional research that was carried out between October 2021 to September 2022. The participants in this research included 220 people who had cardiovascular disease or hypertension for duration of more than six months. Every patient went through a comprehensive evaluation that included obtaining a full medical history, having a clinical exam, having a laboratory investigation, having an echo, and having an abdominal ultrasound. The findings of this study, which involved 220 patients who had cardiovascular disease or hypertension for more than 6 months, revealed the following: 75 (31.5%) of the patients were diagnosed with chronic kidney disease; Significant risk factors for renal impairment include uncontrolled hypertension, congestive heart failure, diuretics, and ACEI or ARBS plus diuretics used concurrently. Uncontrolled hypertension and diuretics are the most accurate predictors of renal impairment. Uncontrolled hypertension is the most avoidable cause of renal impairment; renal atrophy associated with RAAS does not induce renal impairment but does contribute to lower GFR in individuals with CKD. In order to prevent kidney damage and chronic cardiorenal, we have to exercise caution while using ACEIs or ARBS in combination with diuretics, or diuretics solo, and get the congestive heart disease under control.
Description
Volume & Issue
Volume 13 Issue 8
Keywords
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Journal of Cardiovascular Disease Research are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
|
![]() ![]() ![]() ![]() ![]() ![]() |
|
Copyright � 2022 Journal of Cardiovascular Disease Research All Rights Reserved. Subject to change without notice from or liability to Journal of Cardiovascular Disease Research.
For best results, please use Internet Explorer or Google Chrome POLICIES & JOURNAL LINKS
Author Login
Reviewer Login About Publisher Advertising Policy Author's Rights and Obligations Conflict of Interest Policy Copyright Information Digital Archiving & Preservation Policies Editorial Policies Peer Review Policy Editorial & Peer Review Process License Information Plagiarism Policy Privacy Policy Protection of Research Participants (Statement On Human And Animal Rights) Publication Ethics and Publication Malpractice Statement Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Terms of Use |
Contact InformationJournal of cardiovascular Disease Research,
|